Clinical analysis of primary systemic anaplastic large cell lymphoma: A report of 57 cases

Chinese Journal of Cancer

Volumn 28, Issue 1, 2009, Pages 49-53

  Wang, Feng Hua ^a,b   Li, Yu Hong ^a,b   Zeng, Jing ^a,b   Rao, Hui Lan ^a,b   Xia, Zhong Jun ^a,b   Sun, Xiao Fei ^a,b   Huang, Hui Qiang ^a,b   Lin, Tong Yu ^a,b   Jiang, Wen Qi ^a,b   Guan, Zhong Zhen ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anaplastic lymphoma kinase; Chemotherapy; Efficacy; Immunohistochemistry; Non Hodgkin's lymphoma; Prognosis

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN-TYROSINE KINASES; SURVIVAL RATE;

EID: 67749139806     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma [J]. Am J Clin Pathol, 2007,127(5):707-722.
2. Li YH, Rao HL, Jiang WQ, et al. Anaplastic large-cell lymphoma review and 20 cases report [J]. Aizheng, 2000,19(9):914-917. [in Chinese]
3. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues [M]. Lyon, France: IARC Press, 2001:230-235.
4. Cheson BD, Horning SJ, Coiffier B, et al. Report on an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group [J]. J Clin Oncol, 1999,17(4):1244-1253.
5. Stein H, Mason DY, Gerdes J et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells [J]. Blood, 1985,66(4):848-858.
6. Stein H, Foss HD, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features [J]. Blood, 2000,96(12):3681-3695.
7. Falini B. Anaplastic large cell lymphoma: pathological, molecular and clinical features [J]. Br J Haematol, 2001,114(4):741-760.
8. Park SR, Baek JY, Kim DW, et al. Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome [J]. J Korean Med Scl, 2006,21(4):633-638.
9. Li JG, Li GD, Liu WP, et al. Expression of anaplastic lymphoma kinase and survivin proteins in anaplastic large cell lymphoma and its significance [J]. Chin J Pathol, 2006,35(4):213-217. [ in Chinese]
10. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinico-pathological findings and outcome [J]. Blood, 1999,93(8):2697-2706.
11. Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas [J]. Semin Hematol, 2003,40(3):244-256.
12. Rosolen A, Pillon M, Garaventa A, et al. Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol [J]. Cancer, 2005,104(10):2133-2140.
13. Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90 [J]. Blood, 2001,97(12):3699-3706.
14. Mori T, Takimoto T, Katano N, et al. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan [J]. Br J Haematol, 2006,132(5):594-597.
15. Lamant L, de Reyniès A, Duplantier MM, et al. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes [J]. Blood, 2007,109(5):2156-2164.
16. Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity [J]. Blood, 1995, 86(5):1954-1960.
17. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma [J]. Blood, 1999,93(11):3913-3921.
18. Ten Berge RL, Meijer CJ, Dukers DF, et al. Expression levels of apoptosis related proteins predict clinical outcome in anaplastic large cell lymphoma [J]. Blood, 2002,99(12):4540-4546.
19. Savage KJ, Harris NL, Vose JM, et al. ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project [J]. Blood, 2008,111(12):5496-5504.
20. Ten Berge RL, de Bruin PC, Oudejans JJ, et al. ALK-negative anaplastic large cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified [J]. Histopathology, 2003,43(5):462-469.
21. Brugieres L, Deley MC, Pacquement H, et al: CD30 (+) anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology [J]. Blood, 1998,92(10):3591-3598.
22. Le Deley MC, Reiter A, Williams D, et al. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study [J]. Blood, 2008,111(3):1560-1566.
23. Deconinck E, Lamy T, Foussard C, et al. Autologous stem cell transplantation for anaplastic large cell lymphomas: results of a prospective trial [J]. Br J Haematol, 2000,109(4):736-742.
24. Woessmann W, Peters C, Lenhard M, et al. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents - a Berlin-Frankfurt-Münster Group report [J]. Br J Haematol, 2006,133(2):176-182.